Chemotherapeutic efficacy of sulphadimidine, amprolium, halofuginone and chloroquine phosphate in experimental Eimeria bareillyi coccidiosis of buffaloes.
Sulphadimidine, amprolium, halofuginone and chloroquine phosphate were administered to buffalo calves 10 days after experimental infection with Eimeria bareillyi. Animals given sulphadimidine or amprolium remained clinically normal and shed only a few oocysts in their faeces. Halofuginone was found partially effective and chloroquine phosphate completely ineffective in preventing faecal oocyst discharge and intestinal lesions. Sulphadimidine and amprolium treated calves gained weight, but chloroquine treated calves suffered progressive weight loss similar to that of infected untreated controls. No significant alterations of haematological values were observed either in the treated calves or in the untreated controls.
D000670:Amprolium / Q000627:therapeutic use; D000818:Animals; D002020:Buffaloes / Q000469:parasitology*; D002738:Chloroquine / Q000627:therapeutic use; D003048:Coccidiosis / Q000097:blood / Q000188:drug therapy / Q000469:parasitology / Q000662:veterinary*; D003049:Coccidiostats / Q000627:therapeutic use*; D004539:Eimeria / Q000254:growth & development; D007421:Intestine, Small / Q000469:parasitology / Q000473:pathology; D010880:Piperidines; D011799:Quinazolines / Q000627:therapeutic use; D052999:Quinazolinones; D013418:Sulfamethazine / Q000627:therapeutic use
D003049:Coccidiostats; D010880:Piperidines; D011799:Quinazolines; D052999:Quinazolinones; D013418:Sulfamethazine; D002738:Chloroquine; D000670:Amprolium; C010176:halofuginone